Thermo Fisher Scientific Return on Tangible Equity 2010-2022 | TMO

Current and historical return on tangible equity values for Thermo Fisher Scientific (TMO) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Thermo Fisher Scientific Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2022-09-30 $7.03B $-14.69B -38.40%
2022-06-30 $7.44B $-17.29B -50.71%
2022-03-31 $7.60B $-20.08B -69.39%
2021-12-31 $7.73B $-21.18B -109.02%
2021-09-30 $8.57B $-0.13B -301.29%
2021-06-30 $8.60B $-2.44B -190.25%
2021-03-31 $7.92B $-4.60B -128.70%
2020-12-31 $6.38B $-4.21B -83.25%
2020-09-30 $4.88B $-6.83B -53.51%
2020-06-30 $3.71B $-9.00B -36.85%
2020-03-31 $3.67B $-10.60B -34.03%
2019-12-31 $3.70B $-10.05B -33.18%
2019-09-30 $3.59B $-10.58B -30.41%
2019-06-30 $3.54B $-11.89B -28.25%
2019-03-31 $3.17B $-12.03B -24.14%
2018-12-31 $2.94B $-12.74B -20.91%
2018-09-30 $2.57B $-13.47B -17.11%
2018-06-30 $2.39B $-14.36B -14.96%
2018-03-31 $2.25B $-15.63B -14.38%
2017-12-31 $2.23B $-16.56B -14.68%
2017-09-30 $2.33B $-17.46B -16.10%
2017-06-30 $2.27B $-13.03B -16.54%
2017-03-31 $2.17B $-13.59B -16.42%
2016-12-31 $2.02B $-13.76B -15.78%
2016-09-30 $2.00B $-14.44B -16.71%
2016-06-30 $2.00B $-11.13B -18.07%
2016-03-31 $1.99B $-11.95B -17.86%
2015-12-31 $1.98B $-10.24B -17.52%
2015-09-30 $1.97B $-10.91B -16.70%
2015-06-30 $1.97B $-11.51B -15.89%
2015-03-31 $1.74B $-12.44B -13.24%
2014-12-31 $1.90B $-12.41B -13.75%
2014-09-30 $1.64B $-13.24B -14.40%
2014-06-30 $1.48B $-14.40B -16.70%
2014-03-31 $1.48B $-15.08B -23.66%
2013-12-31 $1.27B $-2.72B -35.49%
2013-09-30 $1.31B $-3.31B -31.79%
2013-06-30 $1.28B $-3.92B -28.03%
2013-03-31 $1.24B $-4.41B -26.31%
2012-12-31 $1.18B $-4.81B -24.89%
2012-09-30 $1.09B $-5.12B -23.13%
2012-06-30 $1.07B $-4.45B -22.90%
2012-03-31 $1.35B $-4.54B -34.92%
2011-12-31 $1.33B $-4.75B -50.08%
2011-09-30 $1.34B $-4.87B -98.80%
2011-06-30 $1.34B $-1.36B -862.38%
2011-03-31 $1.06B $0.36B 454.74%
2010-12-31 $1.04B $0.45B 590.58%
2010-09-30 $1.01B $-0.08B 1123.33%
2010-06-30 $0.96B $0.19B 426.58%
2010-03-31 $0.93B $0.13B 492.35%
2009-12-31 $0.85B $0.11B 469.61%
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $220.806B $39.211B
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions Segment, Analytical Instruments, and Specialty Diagnostics.
Stock Name Country Market Cap PE Ratio
Edwards Lifesciences (EW) United States $47.328B 32.57
Alcon (ALC) Switzerland $34.365B 29.59
STERIS (STE) Ireland $19.157B 23.84
Teleflex (TFX) United States $11.379B 18.46
Fresenius Medical Care AG KGaA (FMS) Germany $9.600B 9.64
Penumbra (PEN) United States $8.008B 1916.82
Globus Medical (GMED) United States $7.483B 38.05
Integer Holdings (ITGR) United States $2.426B 19.47
Glaukos (GKOS) United States $2.281B 0.00
Nevro (NVRO) United States $1.601B 0.00
Paragon 28 (FNA) United States $1.511B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.261B 17.96
Artivion (AORT) United States $0.546B 0.00